Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Neoplasms × Other neoplasm × Clear all

Phase

Status

Sponsor Class

OTHER 6 INDUSTRY 5 NETWORK 3 OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 47 Gastrointestinal 23 Gynecologic 10 Other hematologic neoplasm 6 Breast 6 Genitourinary 5 Head & Neck 4 Lymphoid 3 Classical hematology 3 Sarcoma 2 Other 2 Dermatologic 2 CNS 2 Thoracic 1 Other solid neoplasm 1 Other neoplasm 1 NET 1 Myeloid 1 Endocrine 1

Conditions

Precancerous Conditions 2 Uterine Cervical Neoplasms 1 Tobacco Use 1 Rare Malignant Neoplasm 1 Neoplasms 1 Mouth Neoplasms 1 Hypersensitivity 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01837693 2025-06-26

NTCC2

Azienda USL Reggio Emilia - IRCCS

Phase NA Completed

41,127 enrolled

GynecologicOther neoplasm

Uterine Cervical Neoplasms, Hypersensitivity, Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon ⚡